Annette B. Beiderbeck

826 total citations
14 papers, 658 citations indexed

About

Annette B. Beiderbeck is a scholar working on Pulmonary and Respiratory Medicine, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Annette B. Beiderbeck has authored 14 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Ophthalmology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Annette B. Beiderbeck's work include Retinal Diseases and Treatments (4 papers), Retinal Imaging and Analysis (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Annette B. Beiderbeck is often cited by papers focused on Retinal Diseases and Treatments (4 papers), Retinal Imaging and Analysis (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Annette B. Beiderbeck collaborates with scholars based in United Kingdom, Netherlands and United States. Annette B. Beiderbeck's co-authors include Dick J. Richel, Henk‐Jan Guchelaar, Toine C. G. Egberts, Henrik Toft Sørensen, Jette Brommann Kornum, Steffen Christensen, Lars Pedersen, Pia Wogelius, J.W.W. Coebergh and Hubert G. M. Leufkens and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Epidemiology and Journal of Clinical Epidemiology.

In The Last Decade

Annette B. Beiderbeck

12 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette B. Beiderbeck United Kingdom 9 401 299 258 144 96 14 658
Vikas Khurana United States 11 307 0.8× 267 0.9× 227 0.9× 107 0.7× 92 1.0× 37 573
J.T. Thigpen 18 305 0.8× 264 0.9× 190 0.7× 418 2.9× 143 1.5× 95 1.0k
Wen Kong China 18 251 0.6× 203 0.7× 425 1.6× 236 1.6× 401 4.2× 65 887
Mao‐Chih Hsieh Taiwan 18 126 0.3× 359 1.2× 488 1.9× 219 1.5× 168 1.8× 39 915
D.B.Y. Fontein Netherlands 16 254 0.6× 246 0.8× 210 0.8× 454 3.2× 34 0.4× 29 767
Pengfei Kong China 19 237 0.6× 276 0.9× 381 1.5× 678 4.7× 174 1.8× 41 1.1k
C.D.M. Griffith United Kingdom 16 512 1.3× 139 0.5× 208 0.8× 465 3.2× 142 1.5× 27 980
Sundeep Agrawal United States 11 69 0.2× 325 1.1× 179 0.7× 236 1.6× 85 0.9× 34 664
Shigehiko Koga Japan 15 130 0.3× 148 0.5× 242 0.9× 150 1.0× 240 2.5× 35 637
Olga Ace Canada 6 174 0.4× 130 0.4× 156 0.6× 573 4.0× 147 1.5× 8 816

Countries citing papers authored by Annette B. Beiderbeck

Since Specialization
Citations

This map shows the geographic impact of Annette B. Beiderbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette B. Beiderbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette B. Beiderbeck more than expected).

Fields of papers citing papers by Annette B. Beiderbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette B. Beiderbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette B. Beiderbeck. The network helps show where Annette B. Beiderbeck may publish in the future.

Co-authorship network of co-authors of Annette B. Beiderbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Annette B. Beiderbeck. A scholar is included among the top collaborators of Annette B. Beiderbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette B. Beiderbeck. Annette B. Beiderbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ravasio, Roberto, et al.. (2024). Expert Insights from a Delphi-driven Neurologists’ Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in Italy. Journal of Neuromuscular Diseases. 11(2). 411–423. 1 indexed citations
2.
3.
4.
5.
Quhill, Fahd & Annette B. Beiderbeck. (2017). Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN®) versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema. Global & Regional Health Technology Assessment. 4(1). grhta.5000268–grhta.5000268. 13 indexed citations
6.
Yood, Marianne Ulcickas, Karen Wells, Sharon Hensley Alford, et al.. (2012). Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy. Pharmacoepidemiology and Drug Safety. 21(8). 818–827. 15 indexed citations
7.
Beiderbeck, Annette B., et al.. (2012). Prevalence of risk factors among patients with hepatocellular carcinoma (HCC) and the general population in an employer group database.. Journal of Clinical Oncology. 30(4_suppl). 190–190.
8.
Christensen, Steffen, et al.. (2008). Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study. British Journal of Cancer. 98(11). 1870–1875. 8 indexed citations
9.
Kornum, Jette Brommann, Steffen Christensen, Lars Pedersen, et al.. (2008). The incidence of interstitial lung disease 1995–2005: a Danish nationwide population-based study. BMC Pulmonary Medicine. 8(1). 75 indexed citations
10.
Herk‐Sukel, Myrthe P. P. van, Nancy S. Breekveldt‐Postma, Joëlle A. Erkens, et al.. (2007). Incidence of cardiovascular events in breast cancer patients receiving chemotherapy in clinical practice. Pharmacoepidemiology and Drug Safety. 17(2). 125–134. 11 indexed citations
11.
Beiderbeck, Annette B., Miriam Sturkenboom, J.W.W. Coebergh, Hubert G. M. Leufkens, & Bruno H. Stricker. (2004). Misclassification of exposure is high when interview data on drug use are used as a proxy measure of chronic drug use during follow-up. Journal of Clinical Epidemiology. 57(9). 973–977. 10 indexed citations
12.
Beiderbeck, Annette B., et al.. (2004). The Risk of Cancer in Users of Statins. Journal of Clinical Oncology. 22(12). 2388–2394. 440 indexed citations
13.
Beiderbeck, Annette B.. (2003). Prescription Medications Associated with a Decreased Risk of Non-Hodgkin's Lymphoma. American Journal of Epidemiology. 157(6). 510–516. 30 indexed citations
14.
Beiderbeck, Annette B., Elizabeth A. Holly, Miriam Sturkenboom, et al.. (2003). No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands). Cancer Causes & Control. 14(7). 639–644. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vikas Khurana Breakdown of academic impact, for papers by J.T. Thigpen Breakdown of academic impact, for papers by Wen Kong Breakdown of academic impact, for papers by Mao‐Chih Hsieh Breakdown of academic impact, for papers by D.B.Y. Fontein Breakdown of academic impact, for papers by Pengfei Kong Breakdown of academic impact, for papers by C.D.M. Griffith Breakdown of academic impact, for papers by Sundeep Agrawal Breakdown of academic impact, for papers by Shigehiko Koga Breakdown of academic impact, for papers by Olga Ace
Rankless by CCL
2026